Philip Raeth, MD

Articles by Philip Raeth, MD

Image Credit: Adobe Stock Images/garrykillian

EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%

December 8th 2025

The European pharmaceutical market, representing 20% of the global pharmaceutical market, is not a fortress to be feared but an opportunity to be seized.

Latest Updated Articles

Philip Raeth, MD

Articles by Philip Raeth, MD

EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%

Latest Updated Articles

Trending on PharmExec

Is FDA Streamlining Regulations in the Biosimilar Space?

FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma

Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

Five Steps for Successful CGT Commercialization Through Health Systems Partnerships